Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Healthequity (HQY) Accumulated Depreciation & Amortization (2016 - 2026)

Healthequity has reported Accumulated Depreciation & Amortization over the past 14 years, most recently at $154.7 million for Q1 2026.

  • Quarterly results put Accumulated Depreciation & Amortization at $154.7 million for Q1 2026, down 4.8% from a year ago — trailing twelve months through Jan 2026 was $154.7 million (down 4.8% YoY), and the annual figure for FY2026 was $154.7 million, down 4.8%.
  • Accumulated Depreciation & Amortization for Q1 2026 was $154.7 million at Healthequity, up from $116.0 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for HQY hit a ceiling of $162.5 million in Q1 2025 and a floor of $38.7 million in Q2 2025.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $115.2 million (2023), compared with a mean of $101.0 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: grew 24.29% in 2022 and later fell 6.48% in 2025.
  • Healthequity's Accumulated Depreciation & Amortization stood at $120.7 million in 2022, then fell by 4.6% to $115.2 million in 2023, then increased by 7.04% to $123.3 million in 2024, then dropped by 5.92% to $116.0 million in 2025, then skyrocketed by 33.35% to $154.7 million in 2026.
  • The last three reported values for Accumulated Depreciation & Amortization were $154.7 million (Q1 2026), $116.0 million (Q4 2025), and $77.2 million (Q3 2025) per Business Quant data.